Drugs / Tb-PSMA-I&T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07208240 | Aug 2025 → Aug 2028 expected | prostate cancer | Rabin Medical Center | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tb-PSMA-I&T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07208240 ↗ |
| Known as | Tb-PSMA | “Tb-PSMA-I&T (Tb-PSMA)” NCT07208240 ↗ |